Home › Conditions › Community-Acquired Pneumonia (CAP)
Respiratory
Community-Acquired Pneumonia (CAP)
CAP severity is assessed with clinical judgement plus CURB-65 (Confusion, Urea >7mmol/L, RR ≥30, BP <90 systolic or ≤60 diastolic, age ≥65). NG250 (2025) changed where people are cared for: 0–1 discharge home with safety netting; 2 is a shared decision between virtual ward, SDEC, hospital-at-home or admission; ≥3 inpatient care with critical care review if appropriate. CXR and antibiotics both within 4 hours of presentation. Adult courses are 5 days unless they are not clinically stable.
NICE NG250 / CURB-65
The pathway
CURB-65 and where they are cared for
- Confusion (AMT ≤8) · Urea >7 · RR ≥30 · BP <90 systolic or ≤60 diastolic · 65 or over
- 0–1 low risk — discharge home, primary care follow-up, safety netting
- 2 intermediate — virtual ward, SDEC, hospital-at-home or admit, decided with her
- 3–5 high — inpatient, critical care review if appropriate
The score informs the decision; it does not make it. In primary care use CRB65, without the urea.
Investigations
- CXR within 4 hours of presentation
- Lung ultrasound is now recognised — point-of-care, possible heart failure, or pleural complications
- ABG/SpO₂, FBC, U&E, LFTs, CRP on admission
- Moderate or high severity, consider: blood cultures if sepsis suspected · sputum culture · pneumococcal urinary antigen to allow de-escalation · Legionella antigen if risk factors
- CRP or procalcitonin at day 3–4 if treatment failure is a concern
Oxygen
- Target SpO₂ 94–98%
- 88–92% if at risk of hypercapnic respiratory failure
- High-flow nasal oxygen: consider a trial if standard oxygen is not meeting target
Antibiotics — within 4 hours
- Low: amoxicillin 500mg TDS, 5 days. Allergy or atypicals: doxycycline or clarithromycin
- Moderate: amoxicillin 500mg TDS, + clarithromycin if atypicals suspected
- High: co-amoxiclav 500/125mg TDS PO or 1.2g TDS IV + clarithromycin 500mg BD
- High + penicillin allergy: levofloxacin 500mg BD — see MHRA Jan 2024 fluoroquinolone restrictions
- Pregnancy: erythromycin rather than clarithromycin
- Oral first-line if she can take oral medicines and severity does not require IV. If IV, review by 48h and switch
- Check local antimicrobial policy
Stopping at 5 days
- Stop at 5 days unless microbiology says longer, or she is not clinically stable
- Not stable = fever in the past 48h, or more than one of: SBP <90 · HR >100 · RR >24 · SpO₂ <90% on air
A longer course is a decision, not a default.
Supportive care
- IV fluids if unable to take oral or haemodynamically compromised
- DVT prophylaxis
- Analgesia for pleuritic pain
- Physiotherapy for sputum clearance
- Corticosteroids: for high-severity CAP in hospital, consider one for 4–7 days or until discharge. IV hydrocortisone first. Off-label. Note the MHRA warning on fluoroquinolones with corticosteroids
Review, and before they go home
- Worsening: repeat CXR, think atypicals, empyema, influenza, non-infective causes
- IV to oral by 48 hours where severity allows
- Do not discharge if 2 or more in the last 24h: temp >37.5 · RR ≥24 · HR >100 · SBP ≤90 · SpO₂ <90% on air · abnormal mental status · unable to eat unaided
- No routine follow-up CXR. Consider at 6 weeks only for lung cancer risk factors (smoker, over 50), persisting symptoms, or unexplained weight loss
- Recovery: fever gone by 1 week · chest pain and sputum by 4 weeks · cough and breathlessness by 6 weeks · normal by 6 months
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Amoxicillin | 500mg TDS for 5 days | PO | Low and moderate severity (higher doses possible — see BNF). IV if vomiting or severely ill. |
| Clarithromycin | 500mg BD | PO/IV | Covers atypicals (Mycoplasma, Legionella). Add to amoxicillin. |
| Co-amoxiclav | 500/125mg TDS PO or 1.2g TDS IV, 5 days | PO/IV | High severity, with clarithromycin. Oral is first-line if they can swallow and severity allows. |
| Doxycycline | 200mg day 1, then 100mg OD (5 days total) | PO | Penicillin allergy in low or moderate severity, or where atypicals are suspected. |
| Levofloxacin | 500mg BD, 5 days | PO/IV | High severity with penicillin allergy. MHRA January 2024: fluoroquinolones only when other antibiotics are inappropriate — risk of disabling, potentially irreversible effects. Consult microbiology if not suitable. |
When to escalate
- CURB-65 4–5 or rising — HDU/ITU review
- Worsening SpO₂ despite O₂ — NIV or intubation
- Pleural effusion / suspected empyema — ultrasound and urgent respiratory review; drain pus or high-risk infected fluid (pH ≤7.2) when safely accessible
- Not responding to antibiotics at 48h — broaden cover, seek microbiology advice
- Legionella (high-risk travel history) — levofloxacin + rifampicin
- Two or more instability criteria in the last 24 hours — not safe for routine discharge (NG250 1.6.7)
Reference: NICE NG250 Pneumonia: diagnosis and management (2025, replaced NG138 and NG139)
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.